155 related articles for article (PubMed ID: 15582432)
1. Cytotoxic neolignans: an SAR study.
Kong ZL; Tzeng SC; Liu YC
Bioorg Med Chem Lett; 2005 Jan; 15(1):163-6. PubMed ID: 15582432
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol.
Amblard F; Govindarajan B; Lefkove B; Rapp KL; Detorio M; Arbiser JL; Schinazi RF
Bioorg Med Chem Lett; 2007 Aug; 17(16):4428-31. PubMed ID: 17587572
[TBL] [Abstract][Full Text] [Related]
3. Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol.
Luo Y; Xu Y; Chen L; Hu J; Peng C; Xie D; Shi J; Huang W; Xu G; Peng M; Han J; Li R; Yang S; Wei Y
Bioorg Med Chem Lett; 2009 Aug; 19(16):4702-5. PubMed ID: 19589678
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds.
Jada S; Doma MR; Singh PP; Kumar S; Malik F; Sharma A; Khan IA; Qazi GN; Kumar HM
Eur J Med Chem; 2012 May; 51():35-41. PubMed ID: 22424614
[TBL] [Abstract][Full Text] [Related]
5. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
6. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
Ma L; Chen J; Wang X; Liang X; Luo Y; Zhu W; Wang T; Peng M; Li S; Jie S; Peng A; Wei Y; Chen L
J Med Chem; 2011 Oct; 54(19):6469-81. PubMed ID: 21853991
[TBL] [Abstract][Full Text] [Related]
7. Effects of honokiol and magnolol on acute and inflammatory pain models in mice.
Lin YR; Chen HH; Ko CH; Chan MH
Life Sci; 2007 Sep; 81(13):1071-8. PubMed ID: 17826802
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
9. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
[TBL] [Abstract][Full Text] [Related]
10. Honokiol and magnolol: A review of structure-activity relationships of their derivatives.
Dai SY; Qin WX; Yu S; Li C; Yang YH; Pei YH
Phytochemistry; 2024 Jul; 223():114132. PubMed ID: 38714288
[TBL] [Abstract][Full Text] [Related]
11. Effects of Magnolol and Honokiol on the activities of streptococcal glucosyltransferases both in solution and adsorbed on an experimental pellicle.
Jun L; Jifang S; Miaoquan L; Yingyan L; Xihong X
Lett Appl Microbiol; 2004; 39(5):459-65. PubMed ID: 15482438
[TBL] [Abstract][Full Text] [Related]
12. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities.
Kumar A; Kumar Singh U; Chaudhary A
Future Med Chem; 2013 May; 5(7):809-29. PubMed ID: 23651094
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
[TBL] [Abstract][Full Text] [Related]
14. Effect of magnolol on TGF-beta1 and fibronectin expression in human retinal pigment epithelial cells under diabetic conditions.
Kim YS; Jung DH; Kim NH; Lee YM; Kim JS
Eur J Pharmacol; 2007 May; 562(1-2):12-9. PubMed ID: 17321517
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
Kim HM; Bae SJ; Kim DW; Kim BK; Lee SB; Lee US; Kim CH; Moon SK
Int Immunopharmacol; 2007 Aug; 7(8):1083-91. PubMed ID: 17570325
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel compounds related to 1-arylnaphthalene lignans and isoquinolines.
Ding H; Lu W; Li H; Yang L; Zhang Q; Zhou C; Wu X; Baudoin O; Cai J; Guéritte F; Zhao Y
Chem Biodivers; 2005 Sep; 2(9):1217-31. PubMed ID: 17193204
[TBL] [Abstract][Full Text] [Related]
17. Maximizing dermal targeting and minimizing transdermal penetration by magnolol/honokiol methoxylation.
Lin CF; Hwang TL; Al-Suwayeh SA; Huang YL; Hung YY; Fang JY
Int J Pharm; 2013 Mar; 445(1-2):153-62. PubMed ID: 23380623
[TBL] [Abstract][Full Text] [Related]
18. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
[TBL] [Abstract][Full Text] [Related]
19. In vitro growth inhibition of human cancer cells by novel honokiol analogs.
Lin JM; Prakasha Gowda AS; Sharma AK; Amin S
Bioorg Med Chem; 2012 May; 20(10):3202-11. PubMed ID: 22533983
[TBL] [Abstract][Full Text] [Related]
20. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
Li Z; Liu Y; Zhao X; Pan X; Yin R; Huang C; Chen L; Wei Y
Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):95-102. PubMed ID: 18440692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
